免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

OptikView GUP2103CMI

K 號:K191705 · 2020-03-16

決定日期2020-03-16
產品代碼PGY
諮詢委員會RA
決定相當於

器材摘要

OptikView GUP2103CMI is the device name listed in this FDA 510(k) record. The listed applicant is The Linden Group Corp. It received FDA 510(k) clearance on 2020-03-16 under 510(k) number K191705. The device is classified under product code PGY. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the OptikView GUP2103CMI?

OptikView GUP2103CMI is a medical device that received FDA 510(k) clearance on 2020-03-16. The listed applicant is The Linden Group Corp. The 510(k) number is K191705.

When did OptikView GUP2103CMI receive FDA 510(k) clearance?

OptikView GUP2103CMI received FDA 510(k) clearance on 2020-03-16, under 510(k) number K191705.

Who is the listed applicant for OptikView GUP2103CMI?

The FDA 510(k) record lists The Linden Group Corp as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OptikView GUP2103CMI?

The FDA product code for OptikView GUP2103CMI is PGY.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 The Linden Group Corp 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:PGY)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑